Renaissance Technologies’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $479K | Buy |
|
|||||
|
2025
Q1 | $234K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $738K | Sell |
|
|||||
|
2023
Q1 | $1.54M | Buy |
|
|||||
|
2022
Q4 | $874K | Sell |
|
|||||
|
2022
Q3 | $751K | Sell |
|
|||||
|
2022
Q2 | $497K | Sell |
|
|||||
|
2022
Q1 | $847K | Buy |
|
|||||
|
2021
Q4 | $989K | Buy |
|
|||||
|
2021
Q3 | $1.12M | Buy |
|
|||||
|
2021
Q2 | $314K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $249K | Sell |
|
|||||
|
2020
Q2 | $359K | Buy |
|